NP has said Kelly introduced him to Klump who intr
Post# of 148154
The FDA is taking their standard stance. They could end the trial early with strong efficacy and approve. We need to get enrolling fast. Gilead started a month before us and has lobbyists. Plus they have the direct antiviral mechanism that Fauci ,CDC, and FDA seems to favor. Leronlimab is immunodulation with secondary antiviral effect through T cells--the much better mechanism. All just IMO.